MEM

0.00%

0.5¢ memphasys limited.

And there's that Cap raising... Well, they did get creative but...

First 15 Last

Share
Profile

Follow
Grogger

87 Posts.

1

12/12/16

18:43

Post #: 21282014
Share

Originally posted by Grogger ↑

Flagging another cap raise here. S/P cottoned on as well.

"its major investor, Manukan which is part of the Malaysian Sovereign Fund, Xeraya, has put a dampener on the overall achievements and has placed an extra requirement on Memphasys for ongoing litigation funding."

Outlook:

"The development of the next generation SpermSep device and new membranes are expected to be value drivers for the company in the foreseeable future, subject to sufficient funding being available and subject to a successful conclusion of the litigation against PrIME and Manukan."

Don't know how they go about this tbh. Most small ASX companies raise capital with the promise of getting their big product off the ground.

MEM will want it to fund litigation that will go on for the length of a piece of string.

Directors can't keep looking internally for funds forever, and to make a raising even remotely enticing they can't offer shares at the current S/P of 0.004c. Will need to be 0.002c, which kills current shareholders.

MEM needs to get crafty here. A possible cap raising to shareholders is suicide at this point.

Expand

And there's that Cap raising...

Well, they did get creative but capital notes secured against their R&D refund is what you call scraping the bottom of the barrel.

This litigation absolutely must be resolved before they run out of these new funds

MEM Price at posting: 0.6¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

HotCopper Highlights: Your most watched stocks for Week 48, 2024

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

There are more pages in this discussion • 4 more messages in this thread...

First 15 Last

Add MEM (ASX) to my watchlist

(20min delay)
Last 0.5¢		Change 0.000(0.00%)		Mkt cap ! $13.00M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$12.5K	2.5M

Buyers (Bids)

No.	Vol.	Price($)
4	4139600	0.5¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	11066843	9

View Market Depth

No.	Vol.	Price($)
2	60206	0.024
1	14090	0.022
3	497619	0.021
5	649700	0.020
2	130000	0.018

Price($)	Vol.	No.
0.025	153799	6
0.037	18526	1
0.039	1200000	1
0.046	100000	1
0.047	1160000	3

Last trade - 15.45pm 29/11/2024 (20 minute delay)

MEM (ASX) Chart

And there's that Cap raising... Well, they did get creative but...

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

And there's that Cap raising... Well, they did get creative but...

Top Stories

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News